Previous 10 | Next 10 |
Following Recent FDA Approval of Technology Transfer Process, CYTOGAM ® Manufactured by Kamada at its Facility Now Available for Commercial Sales in U.S. New Clinical Data Highlighting Five -year Real-world Survival Benefits of High Risk ...
2023-10-10 07:49:22 ET More on Kamada The AAT Caveat In Kamada's Upbeat Quarter Kamada reports shareholder approval and planned closing of $60M private placement with FIMI opportunity funds Kamada beats Q2 top and bottom line estimates; reaffirms FY23 outlook ...
REHOVOT, Israel, and HOBOKEN, N.J., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, ...
2023-10-09 13:00:03 ET More on InMode, Nano-X, etc. Full Of Potential Red Flags: Breaking Down Nano-X Imaging Nano-X Imaging: Cash Burn Makes It A Hold InMode: Bullish Support Failed To Materialize War between Israel and Hamas pushes U.S.-traded Israeli stock...
2023-09-11 12:28:30 ET More on Kamada Seeking Alpha’s Quant Rating on Kamada Historical earnings data for Kamada Financial information for Kamada The AAT Caveat In Kamada's Upbeat Quarter Kamada: Deep Dive Following FIMI Placement, Rate Buy ...
2023-09-11 02:34:49 ET Summary Kamada shows strong Q2 2023 financials with 59% YoY revenue jump, led by KEDRAB sales, and solid liquidity. Despite growth, AAT deficiency project introduces uncertainty due to weak Phase 2 results, questioning market viability. Investment recomm...
2023-08-30 07:24:36 ET More on Kamada Kamada Ltd. ( KMDA ) Q2 2023 Earnings Call Transcript Kamada: Deep Dive Following FIMI Placement, Rate Buy Kamada beats Q2 top and bottom line estimates; reaffirms FY23 outlook FIMI Opportunity to take ~38% stake in K...
2023-08-17 10:07:42 ET Gainers: CervoMed ( CRVO ) +86% . Tivic Health Systems ( TIVC ) +34% . Jupiter Wellness ( JUPW ) +11% . NEXGEL ( NXGL ) +9% . Kamada ( KMDA ) +8% . Losers: Check-Cap ( CHEK ) -23% . ...
2023-08-16 15:53:03 ET Kamada Ltd. (KMDA) Q2 2023 Earnings Conference Call August 16, 2023 08:30 AM ET Company Participants Brian Ritchie - IR, LifeSci Advisors Amir London - CEO Chaime Orlev - CFO Conference Call Participants Annabel Samimy - Stifel ...
2023-08-16 07:10:46 ET Kamada press release ( NASDAQ: KMDA ): Q2 GAAP EPS of $0.04 beats by $0.02 . Revenue of $37.4M (+58.5% Y/Y) beats by $3.23M . Adjusted EBITDA, as detailed in the tables below, was $6.0 million in the second quarter of 2023, as compared to...
News, Short Squeeze, Breakout and More Instantly...
2024-07-17 17:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-17 04:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...